Table 2

Characteristics of diabetic patients in MHCs and non-MHCs at the start of follow up (T0)

Patient characteristic*

MHCs

(n = 17,045)

Non MHCs

(n = 26,626)


Age, years, %

< 45

20.7%

11.5%

45 to 54

19.7%

14.3%

55 to 64

21.6%

20.7%

65 to 74

18.6%

23.2%

≥75

19.3%

30.3%

Sex, % male

41.9%

43.8%

Indigenous status, %

Indigenous

11.8%

5.6%

Non-Indigenous

88.1%

91.1%

Missing

0.1%

3.3%

Level of social disadvantage

Most disadvantaged

15.1%

10.5%

More disadvantaged

22.7%

21.1%

Little disadvantaged

24.5%

23.8%

Less disadvantaged

17.3%

17.8%

Least disadvantaged

19.0%

25.8%

Missing

1.3%

1.0%

Residential remoteness

Metropolitan

64.8%

70.9%

Rural

25.0%

22.7%

Remote

9.8%

6.3%

Missing

0.4%

0.1%

Charlson comorbidity score, mean (SD)

0.83 (1.62)

0.63 (1.43)

Diabetes recorded before T0, %

34.8%

31.6%

Type of treatment at one year, %

No diabetic medications

53.1%

52.5%

Oral hypoglycemic agents only

39.0%

40.9%

Insulin

7.9%

6.6%

Type of treatment at up to 16 years, %

No diabetic medications

33.6%

32.6%

Oral hypoglycemic agents only

47.7%

51.0%

Insulin

18.7%

16.4%

Type of mental disorders

- Alcohol/drug disorders

8.7%

- Schizophrenia

4.8%

- Affective psychoses

18.6%

- Other psychoses

10.7%

- Neurotic disorders

17.6%

- Personality disorders

2.2%

- Adjustment reaction

5.1%

- Depressive disorder

4.9%

- Other mental disorders

5.9%

- Other than mental or behavioural disorders

21.6%


Abbreviations: MHCs, mental health clients, SD, standard deviation.

*P < 0.001 for all comparisons.

Mai et al. BMC Medicine 2011 9:118   doi:10.1186/1741-7015-9-118

Open Data